FLT4 and neoplasm: Vascular endothelial growth factor C (VEGFC), through binding to its receptor VEGFR3 on lymphatic endothelial cells (LECs), promotes LEC proliferation and migration, resulting in hyperplasia, dilation and increased permeability of lymphatic vessels in the tumor microenvironment 5-7.